Ling Geng

3.8k total citations · 1 hit paper
50 papers, 3.1k citations indexed

About

Ling Geng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Ling Geng has authored 50 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 17 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Ling Geng's work include Angiogenesis and VEGF in Cancer (19 papers), Cancer, Hypoxia, and Metabolism (14 papers) and PI3K/AKT/mTOR signaling in cancer (8 papers). Ling Geng is often cited by papers focused on Angiogenesis and VEGF in Cancer (19 papers), Cancer, Hypoxia, and Metabolism (14 papers) and PI3K/AKT/mTOR signaling in cancer (8 papers). Ling Geng collaborates with scholars based in United States, China and Portugal. Ling Geng's co-authors include Dennis E. Hallahan, Allie Fu, Edwin F. Donnelly, Carolyn Cao, Jeffrey M. Albert, Gerald McMahon, Kwang Woon Kim, Kyle C. Cuneo, Jiahong Lu and Konjeti R. Sekhar and has published in prestigious journals such as Nature Medicine, Cancer Cell and Cancer Research.

In The Last Decade

Ling Geng

50 papers receiving 3.1k citations

Hit Papers

Pharmacological blockade ... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models
    2018 379 citations M. Schulte, Allie Fu et al. Nature Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ling Geng 1.9k 981 866 539 339 50 3.1k
Erina Vlashi 1.7k 0.9× 1.3k 1.3× 1.0k 1.2× 335 0.6× 308 0.9× 48 3.0k
Gilbert Spizzo 2.1k 1.1× 1.7k 1.8× 723 0.8× 488 0.9× 351 1.0× 70 3.8k
David R. Shalinsky 2.3k 1.2× 1.7k 1.7× 1.3k 1.5× 1.0k 1.9× 294 0.9× 52 4.3k
Elisabetta Marangoni 1.8k 0.9× 1.5k 1.5× 887 1.0× 449 0.8× 213 0.6× 111 3.4k
J Mattern 1.7k 0.9× 1.5k 1.5× 731 0.8× 520 1.0× 452 1.3× 140 3.4k
Zhenhe Suo 1.8k 0.9× 1.3k 1.3× 872 1.0× 447 0.8× 208 0.6× 107 3.1k
Nils Cordes 2.2k 1.1× 1.9k 1.9× 815 0.9× 615 1.1× 431 1.3× 132 4.5k
Adrian M. Jubb 2.5k 1.3× 1.6k 1.7× 1.0k 1.2× 630 1.2× 173 0.5× 50 4.0k
Joachim Drevs 2.0k 1.0× 1.1k 1.2× 757 0.9× 631 1.2× 510 1.5× 75 3.4k
Olav Engebraaten 1.3k 0.7× 925 0.9× 700 0.8× 294 0.5× 402 1.2× 87 2.7k

Countries citing papers authored by Ling Geng

Since Specialization
Citations

This map shows the geographic impact of Ling Geng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Geng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Geng more than expected).

Fields of papers citing papers by Ling Geng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Geng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Geng. The network helps show where Ling Geng may publish in the future.

Co-authorship network of co-authors of Ling Geng

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Geng. A scholar is included among the top collaborators of Ling Geng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Geng. Ling Geng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xuan, Wenya Du, Tao Ma, et al.. (2023). NK-derived exosome miR-1249-3p inhibits Mycobacterium tuberculosis survival in macrophages by targeting SKOR1. Cytokine. 175. 156481–156481. 2 indexed citations
2.
Wang, Jianbo, Dimitra K. Georgiou, Xiaoxia Wen, et al.. (2023). Feasibility of [18F]FSPG PET for Early Response Assessment to Combined Blockade of EGFR and Glutamine Metabolism in Wild-Type KRAS Colorectal Cancer. Tomography. 9(2). 497–508. 9 indexed citations
3.
Ding, Kexin, Hui Chen, Yong Wang, et al.. (2022). Emergency medical service utilization among acute ischemic stroke patients in Beijing: An observational study. Frontiers in Neurology. 13. 969947–969947. 3 indexed citations
4.
Cohen, Allison S., Ling Geng, Ping Zhao, et al.. (2020). Combined blockade of EGFR and glutamine metabolism in preclinical models of colorectal cancer. Translational Oncology. 13(10). 100828–100828. 35 indexed citations
5.
Schulte, M., Allie Fu, Ping Zhao, et al.. (2018). Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models. Nature Medicine. 24(2). 194–202. 379 indexed citations breakdown →
6.
Sekhar, Konjeti R., Mouadh Benamar, Amudhan Venkateswaran, et al.. (2014). Targeting Nucleophosmin 1 Represents a Rational Strategy for Radiation Sensitization. International Journal of Radiation Oncology*Biology*Physics. 89(5). 1106–1114. 28 indexed citations
7.
Sekhar, Konjeti R., P. Narsimha Reddy, Peter A. Crooks, et al.. (2011). The Novel Chemical Entity YTR107 Inhibits Recruitment of Nucleophosmin to Sites of DNA Damage, Suppressing Repair of DNA Double-Strand Breaks and Enhancing Radiosensitization. Clinical Cancer Research. 17(20). 6490–6499. 21 indexed citations
8.
Thotala, Dinesh, Ling Geng, Amy K. Dickey, Dennis E. Hallahan, & Eugenia M. Yazlovitskaya. (2010). A New Class of Molecular Targeted Radioprotectors: GSK-3β Inhibitors. International Journal of Radiation Oncology*Biology*Physics. 76(2). 557–565. 51 indexed citations
9.
Cuneo, Kyle C., Ling Geng, Allie Fu, et al.. (2008). SU11248 (Sunitinib) Sensitizes Pancreatic Cancer to the Cytotoxic Effects of Ionizing Radiation. International Journal of Radiation Oncology*Biology*Physics. 71(3). 873–879. 68 indexed citations
10.
Cuneo, Kyle C., et al.. (2007). Histone deacetylase inhibitor NVP-LAQ824 sensitizes human nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation. Anti-Cancer Drugs. 18(7). 793–800. 33 indexed citations
11.
Geng, Ling, Kyle C. Cuneo, Michael K. Cooper, et al.. (2007). Hedgehog signaling in the murine melanoma microenvironment. Angiogenesis. 10(4). 259–267. 31 indexed citations
12.
Geng, Ling, Kyle C. Cuneo, Allie Fu, et al.. (2006). Histone Deacetylase (HDAC) Inhibitor LBH589 Increases Duration of γ-H2AX Foci and Confines HDAC4 to the Cytoplasm in Irradiated Non–Small Cell Lung Cancer. Cancer Research. 66(23). 11298–11304. 143 indexed citations
13.
Cuneo, Kyle C., Ling Geng, Jiahuai Tan, et al.. (2006). SRC family kinase inhibitor SU6656 enhances antiangiogenic effect of irradiation. International Journal of Radiation Oncology*Biology*Physics. 64(4). 1197–1203. 23 indexed citations
14.
Huamani, Jessica, Kenneth J. Niermann, Haakil Lee, et al.. (2006). Noninvasive Assessment of Tumor Vasculature Response to Radiation-Mediated, Vasculature-Targeted Therapy Using Quantified Power Doppler Sonography. Journal of Ultrasound in Medicine. 25(12). 1507–1517. 22 indexed citations
15.
Geng, Ling, et al.. (2005). Dynamic monitoring of LLC lung metastasis development and prevention. Cancer Research. 65. 1094–1094. 1 indexed citations
16.
Geng, Ling, Eric T. Shinohara, Dong Kim, et al.. (2005). STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 64(1). 263–271. 44 indexed citations
17.
Lü, Bo, Ling Geng, Amy Musiek, et al.. (2004). Broad spectrum receptor tyrosine kinase inhibitor, SU6668, sensitizes radiation via targeting survival pathway of vascular endothelium. International Journal of Radiation Oncology*Biology*Physics. 58(3). 844–850. 17 indexed citations
18.
Geng, Ling, et al.. (2004). Radiation-guided drug delivery to tumor blood vessels results in improved tumor growth delay. Journal of Controlled Release. 99(3). 369–381. 21 indexed citations
19.
Donnelly, Edwin F., et al.. (2001). Quantified Power Doppler US of Tumor Blood Flow Correlates with Microscopic Quantification of Tumor Blood Vessels. Radiology. 219(1). 166–170. 68 indexed citations
20.
Hallahan, Dennis E., Shimian Qu, Ling Geng, et al.. (2001). Radiation-Mediated Control of Drug Delivery. American Journal of Clinical Oncology. 24(5). 473–480. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Erina Vlashi Breakdown of academic impact, for papers by Gilbert Spizzo Breakdown of academic impact, for papers by David R. Shalinsky Breakdown of academic impact, for papers by Elisabetta Marangoni Breakdown of academic impact, for papers by J Mattern Breakdown of academic impact, for papers by Zhenhe Suo Breakdown of academic impact, for papers by Nils Cordes Breakdown of academic impact, for papers by Adrian M. Jubb Breakdown of academic impact, for papers by Joachim Drevs Breakdown of academic impact, for papers by Olav Engebraaten
Rankless by CCL
2026